Vancomycin-Resistant Enterococci (VRE) (cont.)
Mary D. Nettleman, MD, MS, MACP
Mary D. Nettleman, MD, MS, MACP is the Chair of the Department of Medicine at Michigan State University. She is a graduate of Vanderbilt Medical School, and completed her residency in Internal Medicine and a fellowship in Infectious Diseases at Indiana University.
Charles Patrick Davis, MD, PhD
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
In this Article
- Vancomycin-resistant enterococci (VRE) facts
- What are vancomycin-resistant enterococci (VRE)?
- What causes a vancomycin-resistant enterococcal (VRE) infection?
- What are risk factors for vancomycin-resistant enterococci (VRE) infections?
- How are vancomycin-resistant enterococci (VRE) transmitted?
- What are the symptoms and signs of a vancomycin-resistant enterococcal (VRE) infection?
- How do physicians diagnose vancomycin-resistant enterococcal (VRE) infections?
- What is the treatment for a vancomycin-resistant enterococcal (VRE) infection?
- What is the prognosis of a vancomycin-resistant enterococcal (VRE) infection?
- What are the complications of VRE infections?
- Is it possible to prevent vancomycin-resistant enterococci (VRE) infections?
- What precautions should people take when tending to someone with a vancomycin-resistant enterococcal (VRE) infection?
- What research is being done on vancomycin-resistant enterococci (VRE)?
- Where can people find more information on vancomycin-resistant enterococci (VRE) infections?
What are vancomycin-resistant enterococci (VRE)?
Enterococci are a group of gram-positive, round-shaped bacteria that commonly live in the gut, although they can cause infection anywhere in the body. They are resistant to several antibiotics, but in the past, physicians could rely on the drug vancomycin to effectively treat enterococcal infections. In recent decades, however, some enterococci have become resistant to vancomycin. The two main species that cause problems are vancomycin-resistant Enterococcus faecium and vancomycin-resistant Enterococcus faecalis. E. faecium is the most common species of VRE. These bacteria are not the same genus as other common fecal bacteria such as E. coli.
Vancomycin resistance is acquired when a sensitive Enterococcus acquires a special piece of DNA called a plasmid that permits the bacteria to become resistant to vancomycin. The new strains are called vancomycin-resistant enterococci (VRE). One concern is that VRE strains appear able to transfer vancomycin resistance to unrelated bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) and these strains are renamed VRSA. In addition, VRE organisms, like MRSA, are usually resistant to more than one antibiotic.
VRE can be spread from person to person and are an increasing problem in hospitals and chronic-care facilities. Approximately 30% of all enterococcal infections are now caused by vancomycin-resistant strains (VRE).
What causes a vancomycin-resistant enterococcal (VRE) infection?
VRE can exist in the body without causing infection, in which case a patient is said to be colonized with VRE. Colonization usually occurs in the bowel. If the number of VRE bacteria increases, they can invade the bloodstream or spread locally to cause an abdominal abscess or urinary tract infection. Once in the bloodstream, VRE can cause meningitis, pneumonia, or infection of a heart valve (endocarditis). VRE may also be introduced directly into an open sore or wound, causing a wound infection. The bacteria produce several substances, including proteases that help them break down the normal barriers between the gut tissue and the bloodstream.
Find out what women really need.